China Resources Hubei Pharmaceutical

China Resources Hubei Pharmaceutical Co., Ltd. (hereinafter referred to as "China Resources Hubei") is a provincial-level platform company under China Resources Pharmaceutical Group, with a registered capital of 352 million yuan and legal representative Wang Yong. It is a large-scale modern pharmaceutical distribution enterprise integrating pharmaceutical wholesale, hospital direct sales, commercial distribution, e-commerce, and logistics delivery. Its business scope includes Chinese patent medicines, Chinese herbal medicines, Chinese herbal decoction pieces, chemical drug preparations, antibiotic preparations, biochemical drugs, biological products, psychotropic drugs, protein anabolic agents and peptide hormones, chemical reagents, medical devices, and industrial investment, operating over 15,000 product specifications, with nearly 2,000 employees and annual sales revenue of 8 billion yuan. It ranks among the "Top 15 Chinese Pharmaceutical Distribution Enterprises," "China AAA Credit Enterprise," "China AAAA Logistics Enterprise," and ranks second in the "Top Ten Pharmaceutical Enterprises in Hubei Province," and ranks first in the total distribution volume of basic drugs for primary medical institutions in Hubei Province.
China Resources Hubei is a group-managed enterprise. The company owns 28 wholly-owned, holding, and participating second-level subsidiaries in Beijing, Guangzhou, Taiyuan, and within Hubei Province in Wuhan, Jingzhou, Yichang, Enshi, Jianli, Shiyan, and Lichuan. It possesses an information, capital, and logistics platform combining unified management and independent operation, as well as a marketing network advantage of nationwide integrated planning and decentralized promotion, maintaining good cooperative relationships with more than 10,000 domestic production, trading, and scientific research institutions.
China Resources Hubei is an innovative and growing enterprise. The company advocates the core values of "integrity, performance orientation, people orientation, and innovative development," and emphasizes learning, education, process management, and performance assessment. The company has invested nearly 1 billion yuan in Beijing, Wuhan, Yichang, Shiyan, and other places, building large-scale modern pharmaceutical logistics centers with a total warehouse area of over 72,000 square meters and an annual throughput of 17.1 million pieces. Equipped with world-class warehousing equipment, facilities, cold chain systems, information systems, picking, transmission and delivery systems, and WMS management, these are currently the largest modern pharmaceutical logistics centers in North China and Central China. The company participates in the construction of the "Five-in-One" overall layout in Hubei and the whole country with a new posture, contributing to the comprehensive building of a moderately prosperous society and accelerating the great rejuvenation of the Chinese nation.